Dose selection is critical in clinical settings and standard dosing protocols are not suitable for every patient, due to the significant degree of inter- and intra-individual variability of their pharmacokinetic response. Pharmacokinetic models can be used as clinical support tools to suggest individualized, optimal dosages according to each patient's characteristics. We consider the case study of high-dose methotrexate administration for the application of a physiologically-based pharmacokinetic model, with the goal of obtaining model-informed dosages that we also compare with the standard dosing protocol. The results demonstrate the feasibility of this approach, the potential benefits of improved individualized dosages, and the importance of establishing rational and well-defined administration targets.

Application of a Pharmacokinetic Model to Inform the Optimal Dose for Individualized Drug Administration / Pesenti, G.; Foppoli, M.; Savoca, A.; Manca, D.. - 48:(2020), pp. 709-714. [10.1016/B978-0-12-823377-1.50119-1]

Application of a Pharmacokinetic Model to Inform the Optimal Dose for Individualized Drug Administration

Foppoli M.
Secondo
;
2020-01-01

Abstract

Dose selection is critical in clinical settings and standard dosing protocols are not suitable for every patient, due to the significant degree of inter- and intra-individual variability of their pharmacokinetic response. Pharmacokinetic models can be used as clinical support tools to suggest individualized, optimal dosages according to each patient's characteristics. We consider the case study of high-dose methotrexate administration for the application of a physiologically-based pharmacokinetic model, with the goal of obtaining model-informed dosages that we also compare with the standard dosing protocol. The results demonstrate the feasibility of this approach, the potential benefits of improved individualized dosages, and the importance of establishing rational and well-defined administration targets.
2020
Inglese
Computer Aided Chemical Engineering
Elsevier B.V.
48
709
714
6
Sì, ma tipo non specificato
Internazionale
Goal 3: Good health and well-being
Methotrexate
Model informed precision dosing
Optimal dosage
Personalized medicine
Pharmacokinetics
No
2 Contributo in Volume::2.1 Contributo in volume (Capitolo o Saggio)
4
268
Application of a Pharmacokinetic Model to Inform the Optimal Dose for Individualized Drug Administration / Pesenti, G.; Foppoli, M.; Savoca, A.; Manca, D.. - 48:(2020), pp. 709-714. [10.1016/B978-0-12-823377-1.50119-1]
none
Pesenti, G.; Foppoli, M.; Savoca, A.; Manca, D.
info:eu-repo/semantics/bookPart
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/20.500.11768/183804
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus 1
  • ???jsp.display-item.citation.isi??? 1
social impact